- CEO
- Petri Toljamo
- Full Time Employees
- 528
- Sector
- Technology services
- Industry
- Information technology services
- Address
- Ritaharjuntie 1 Oulu NO Finland 90590
- IPO Date
- May 31, 2002
- Business
- Bittium Oyj develops reliable and secure communications and connectivity solutions leveraging over 40 years of expertise in advanced radio communication technologies; it provides innovative products and services, customized solutions based on its product platforms, and R&D services for customers in defense, security, public safety, telecommunications, Internet of Things, and healthcare industries. The company offers tactical communications systems including Tough SDR software-defined radios, TAC WIN Smart Link 360 waveform functionality, and wireless IP networks; secure mobile devices such as the Bittium Tough Mobile 3 5G smartphone with quantum-secure features; information security solutions for mobile devices and portable computers; biosignal measuring products for cardiology and neurophysiology like Bittium Faros, HolterPlus, Respiro home sleep apnea testing, ECG electrodes, and cardiac monitoring tools; and engineering services specializing in embedded AI, secure connectivity, and high-end product development. Founded in 1985 and headquartered in Oulu, Finland, Bittium operates primarily in Europe, the United States, and Asia, with subsidiaries including Bittium Wireless Ltd; it lists on Nasdaq Helsinki under ticker BITTI.HE and reports net sales of EUR 85.2 million and operating profit of EUR 8.6 million for 2024. Recent developments include launching the Bittium Tough Mobile 3 secure phone and entering a strategic partnership with HMD Secure Oy for its platform and licensing security features; signing a Letter of Intent with Indra Group for software-defined radio technology collaboration and a long-term partnership agreement between Bittium Wireless Ltd and the Finnish Defence Forces through 2036; acquiring a 25% stake in MarshallAI to enhance AI capabilities across defense and medical segments; receiving CE approval for Bittium Respiro sleep apnea solution; updating long-term financial targets to 20-30% annual revenue growth and 10-20% operating profit margins through 2026-2028 with refined strategy emphasizing international expansion, AI integration, and inorganic growth opportunities; and opening a London office to bolster UK sales including with BAE Systems.